Construction of Responsive Nanocarriers and Their Key Role in the Development of Novel Sustained-Release Drugs
Abstract
in cancer, chronic disease, gene therapy, inflammation, and vaccine delivery. Studies confirm their advantages in targeting, release efficiency, and
biocompatibility. Despite challenges in degradation, stability, and scalability, they offer promising solutions for precise and personalized therapy.
Keywords
Full Text:
PDFReferences
[1] Xiong C Y, Lei Z X, Sun T L. Research progress on ROS-responsive nanocarriers for bacterial infection therapy[J]. Drug Evaluation
Research, 2024, 43(11): 1804-1812.
[2] Lu G L, Jin Y T, Liu X R, et al. Platinum drug delivery system based on stimulus-responsive polymer nanocarriers[J]. Polymer Bulletin,
2024, 37(10): 1317-1336.
[3] Han K S, Wang X L, Ren T, et al. Construction and evaluation of multifunctional nanocarriers loaded with nitrosoureas[J]. Chemical
Reagents, 2023, 45(09): 19-28.
[4] Li H, Zhang J B, Li J X, et al. Research progress on intelligent responsive nanocarriers for nucleic acid drug delivery[J]. China Pharmacy, 2022, 33(09): 1147-1152.
[5] Zhang Y L, Li G, Zhang X G, et al. Construction and performance of bacteria-responsive nanocarriers[J]. Ion Exchange and Adsorption,
2022, 38(02): 97-105.
[6] Zhang Y X, Wang J W. Research progress on responsive polymer nanomaterials as drug carriers[J]. Polymer Bulletin, 2021, (04): 1-6.
[7] Su Y H, Zhang W L, Shen Y, et al. Research progress on red blood cell-based nanocarrier drug delivery systems[J]. Pharmaceutical Research, 2024, 43(03): 255-260+281.
[8] Zhou W, Yang K G, Zhao B F, et al. ROS-responsive nanocarriers[J]. Chromatography, 2021, 39(02): 118-124.
DOI: http://dx.doi.org/10.70711/frim.v3i8.6956
Refbacks
- There are currently no refbacks.
